INBICON A/S: Financial statements 2017
CVR: 27036635
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
INBICON A/S (CVR 27036635) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -4,419,000 and a net result of DKK -7,621,000 compared with DKK -16,756,000 the year before. Equity in the 2017 report amounted to DKK 21,508,000. The solvency ratio was 97.3%.
- Gross Profit
- DKK -4,419,000
- Profit/Loss
- DKK -7,621,000
- Equity
- DKK 21,508,000
- Total Assets
- DKK 22,094,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -4.4 mio. | -7.6 mio. | 21.5 mio. | - |
| 2016 | - | -13.8 mio. | -16.8 mio. | 47.1 mio. | - |
| 2015 | - | -43.2 mio. | -35.1 mio. | 63.9 mio. | - |
| 2014 | 14 mio. | -61.4 mio. | -45.4 mio. | 59 mio. | - |
| 2013 | 16.8 mio. | -84 mio. | -68.5 mio. | 44.4 mio. | - |
Official annual report
Keep an eye on INBICON A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of June 8, 2017, Mikael Brandt has joined the board of directors of INBICON A/S.
As of June 8, 2017, Jacob Moesgård has left the board of directors of INBICON A/S.
INBICON A/S has published its annual report for 2016. Gross profit came to DKK -13,750,000, and the net result was DKK -16,756,000.
As of February 23, 2017, Hannes Reuter is registered as director of INBICON A/S.
As of February 23, 2017, Anna-Lena Elisabet Jeppsson has stepped down as director of INBICON A/S.
About INBICON A/S
INBICON A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2003. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ELSAM BIOSYSTEMS A/S and KR 354 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. The company has 0 employees (2011). In 2025, the company reported a net result of DKK -3,447,000 compared with DKK 7,237,000 the year before. Equity in the 2025 report amounted to DKK 35,752,000.